RBR-2v2mwkz
Completed
Phase 3
Pharmacokinetics and placental transfer studies of betamethasone in twin pregnancies
Faculdade de Medicina de Ribeirão Preto0 sitesFebruary 10, 2021
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Faculdade de Medicina de Ribeirão Preto
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Adult women (\> 18 years) with single or multiple pregnancies of morphologically normal fetuses, with gestational age between 24 \- 34 weeks; risk of imminent prematurity and therefore, with an indication of antenatal administration of betamethasone to stimulate fetal maturity; normal biochemical and hematological parameters.
Exclusion Criteria
- •Smoking, alcoholism, and/or use of illegal substances; maternal diseases that develop vasculopathy and influence uteroplacental flow, such as hypertension, uncontrolled diabetes, heart disease, kidney disease, or thrombophilia; fetuses with congenital anomaly; injury identification in target organs by laboratory examination.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
Maternal pharmacokinetics and pharmacodynamics of nicardipine (iv) during treatment of severe hypertension in pregnancy.preeclampsia1002690810057166NL-OMON36863Erasmus MC, Universitair Medisch Centrum Rotterdam40
Active, not recruiting
Not Applicable
What is the effect of nicardipine on the pregnant woman with severe hypertension and how is nicardipine excreted?EUCTR2012-005330-10-NLErasmus University Medical Centre
Recruiting
Phase 3
nderstanding metabolism of drug and changes in human functioning for drug given to pregnant women at risk of late preterm birthHealth Condition 1: P220- Respiratory distress syndrome of newbornCTRI/2023/10/058248World Health Organization
Active, not recruiting
Phase 1
Pharmacokinetic and Placental Transfer of LevetiracetamEpilepsy in pregnancyMedDRA version: 21.0Level: PTClassification code 10015037Term: EpilepsySystem Organ Class: 10029205 - Nervous system disordersTherapeutic area: Diseases [C] - Nervous System Diseases [C10]EUCTR2020-004878-22-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS50
Recruiting
Not Applicable
Study on Pharmacokinetics and Pharmacodynamics of high dose Daptomycin.Infectious DiseaseJPRN-UMIN000017226Keio University20